Fovea Pharmaceuticals
French biopharmaceutical company that discovers and develops drugs for the treatment of ocular diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD185—278m (Dealroom.co estimates Dec 2007.)
Company register number 482218203
Paris Île-de-France (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
€20.5m | Series A | ||
€40.0m | Series B | ||
$30.0m | Series B | ||
N/A | Acquisition | ||
| Total Funding | AUD149m | ||
Related Content
Recent News about Fovea Pharmaceuticals
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.